Genenta Science
  • who we are
  • our companies
  • stories
  • investors
Select Page
← Press Coverage

BioWord

Italian firm Genenta raises $15M to advance Temferon interferon-based cell therapy

27 April 2022
Italian firm Genenta raises $15M to advance Temferon interferon-based cell therapy Apri immagine a schermo intero ↗
CONTACT
NEWSROOM
© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963